Shortly after we began a long-term study of the histopathology of azotaemic renal osteodystrophy some eight years ago one of us observed an apparent increase in the number of marrow mast cells in toluidine blue stained sections of iliac bone from patients with chronic azotaemia. More recently, Neiman et al (1972) , in a letter to the Lancet, ieferred briefly to their finding of increased numbers of mast cells in the spleen and bone marrow of patients with uraemia.
There is little quantitative information in the literature concerning marrow mast cells in man. In the past, the finding of such cells has been regarded as abnormal (Fadem, 1951) and it is now recognized that mast cells are present in normal bone marrow (Johnstone, 1954; Selye, 1965) . The purpose of the present paper is to report quantitative observations on the mast cells in histological sections of iliac bone marrow in 45 patients with chronic renal failure. For comparison samples of iliac bone were obtained at necropsy from 61 cases of sudden death. Numbers of marrow mast cells have been considered in relation to the severity of osteitis fibrosa, the presence of Received for publication 26 June 1975. 947 excess osteoid, and osteomalacia, all of which are features of azotaemic renal osteodystrophy.
Material and Methods

BONE
Samples of iliac bone were examined from45 patients with chronic renal failure due to a variety of renal disorders. Iliac bone was obtained by transilial trephine bone biopsy in 22 patients and at necropsy in 23. Of the patients coming to necropsy, 11 had terminal peritoneal dialysis, one had a terminal haemodialysis, and two had been treated by peritoneal dialysis for two months. The biopsy patients were near end stage renal failure. Three had been treated by peritoneal dialysis for two to three months, and 12 required dialysis after periods varying from a few days up to three months after bone biopsy.
Control iliac bone samples were obtained at necropsy from 61 previously physically healthy individuals after sudden death due to a variety of causes such as trauma and poisoning.
Blocks of iliac bone were fixed in neutral 10% formalin, decalcified in formic acid, and double embedded using low viscosity nitrocellulose; 5 ,u sections were stained by 0-05 % toluidine blue solution at pH 3-8.
MAST CELLS IN MARROW AND FIBROUS TISSUE
We have regarded as marrow tissue mast cells any connective tissue cell possessing cytoplasmic granules that stain metachromatically. Basophils possess similar granules but differ morphologically from mast ce!ls in that they are generally smaller and have a lobulated nucleus. Since human basophilic gianules are water soluble, metachromasia is lost after aqueous fixation, and basophils are not liable to be confused with mast cells in histological sections.
Mast cells were counted in the marrow of cancellous bone in a square measuring 0 5 x 0-5 cm marked out on the cover slip in an area immediately beneath the iliac crest in the case of the necropsy samples and in the middle of the biopsy specimens, using x 40 objective and x 10 eyepiece incorporating a squared graticule. The proportion of total bone within the measured area was determined using a point-counting technique (Ellis and Peart, 1972) and the number of mast cells per mm2 of marrow was then calculated. In 24 of the patients with renal failure the amount of marrow fibrous tissue resulting from osteitis fibrosa was also measured using a point-counting technique (Ellis and Peart, 1973) . In these patients, mast cells were counted separately in fibrous tissue and in mixed fatty and cellular marrow to ascertain whether or not mast cells were concentrated in the fibrous tissue.
OSTEITIS FIBROSA, EXCESS OSTEOID, AND
OSTEOMALACIA
The severity of osteitis fibrosa was assessed semiquantitatively on a scale of grades from 0 to 5, and the number of osteoclasts and amount of woven bone were determined as previously described (Ellis and Peart, 1973) . The amount of osteoid, expressed as a percentage of the measured area, and the percentage mineralization of cancellous bone were determined by a point-counting technique using undecalcified sections (Ellis and Peart, 1972) . Osteomalacia was diagnosed on the basis of the presence of an excess of osteoid with abnormally wide osteoid seams and a reduced or absent calcification front (Ellis and Peart, 1973; Ellis, 1973) .
(P > 0-10) between the means for males (4 70 per mm2) and females (2-65 per mm2). Plotting the distribution of mast cell values iD relation to age revealed no significant relationship in males or females. As the figure shows, there was considei able variation in the number of marrow mast cells between individuals, and the distribution is not normal. Mast cells were found in all but three of the 61 samples examined. The highest value (33-76 per mm2) was in an 11-year old boy and this in the area immediately contiguous with the zone of endochondral ossification beneath the iliac crest. A second count at a distance of 1-0 cm below this gave a lower value of 4-67 mast cells per mm2. In three older individuals aged 21 to 22 years, duplicate counts made at distances of 0 5 cm and 1-5 cm below the crest revealed less marked differences, the paired values being 3-18 and 7-42, 6-32 and 4-80, and 4-7 and 168 mast cells per mm2 of bone marrow, respectively.
The majority (82%) of the control subjects had mast cell values within the range 0 to 4 99 per mm2, and in 37-7 % of individuals there was < 1 mast cell per mm2. The six individuals (10%) with > 10 mast cells per mm2 were males aged 11 to 47 years. The mode of death was unrelated to the highei values. Thus one died from asphyxia trapped in a disused pit, one from multiple injuries, and the others from various poisons including carbon monoxide, barbitu- (Johnstone, 1954) , whereas human mast cell granules are relatively insoluble in watery fixatives (Johnstone, 1954; Kramer and Windrum, 1955; Sagher and Even-Paz, 1967) . The solubility of mast cell granules varies between different animal species. Mouse, rat, and human mast cell granules are well preserved after formalin fixation but non-aqueous fixatives are necessary in the case of lower vertebrates and in the guinea-pig and dog (Benditt and Dunn, 1963 In the present study we are concerned mainly with a comparison of two different groups of subjects so that any differences encountered between the groups as a whole may be regarded as meaningful.
In the control necropsy series comprising 61 individuals, the distribution of values for the numbers of marrow mast cells was not a normal one and we have therefore not quoted the mean and standard error. The control values were range 0-33-76, arithmetic mean 3 93, and median 1-95 mast cells per mm2 marrow. We have no explanation for the fact that 10 % of individuals had mast cell values in excess of 10 per mm2 marrow, and these values were apparently unrelated to the mode of death.
In the group of 45 patients with chronic renal failure taken as a whole there were significantly more mairow mast cells (arithmetic mean 13 75 and median 9 55 per mm2) than in the control group (P < 0-001). Again the distribution of values was not a normal one and comparisons between the various groups throughout this study have been made using the appropriate Mann-Whitney test (Snedecor and Cochran, 1971) . Within the renal group there was a significantly higher range of mast cell values for those samples obtained by iliac crest biopsy as compared to those obtained at necropsy. This raises the possibility that better preservation of mast cells and hence easier recognition result from rapid fixation of the biopsy samples, whereas in the case of the necropsy specimens there would inevitably be a delay between death and the subsequent fixation of tissues at the time of the necropsy. We cannot exclude this possibility, but it does not alter the significance of the increased numbers of marrow mast cells observed in renal disease since even in the necropsy specimens significantly more mast cells occurred in the renal failure patients than in the controls (P < 0-001). Furthermore, we have observed in serial bone biopsies from patients treated by renal transplantation, where conditions of fixation of specimens were identical, a return of marrow mast cells to the control range.
The difference between renal biopsy and necropsy cases may also be attributable in part to the fact that there were more severe examples of osteitis fibrosa in the biopsy series with more marrow fibrous tissue which included frequent mast cells. In the bone of patients with chronic renal failure there was com-monly evidence of osteitis fibrosa due to secondary hyperparathyroidism. Mast cells were often conspicuous within the zones of marrow fibrosis in such cases, and we were able to demonstrate a significant relationship between the total number of marrow mast cells and the amount of marrow fibrosis. We have also observed mast cells in the fibrous tissue of organizing iliac bone biopsy sites, and it is well recognized that mast cells may occur in many sites ofrepair where there is connective tissue proliferation such as fracture callus (Selye, 1965; Lindholm et al, 1969; Lindholm and Lindholm, 1970) . From our observations we are not certain that all the cells counted as mast cells in the marrow fibrous tissue are true mast cells. Some of the cells may have been fibroblasts which had taken up metachromatic granules from adjacent disrupted mast cells (Higginbotham et al, 1956) .
That the mast cells in marrow fibrous tissue did not alone account for the increased numbers of marrow mast cells in renal failure was shown by the finding of increased numbers of mast cells in the mixed fatty and haemopoietic marrow of these patients. This suggests that there is someotherfactor in renal failure which is responsible, at least in part, for the increase in marrow mast cells. This concept is supported by the report that mast cells are increased in tissues other than the bone marrow in chronic renal failure, such as the spleen (Neiman et al, 1972) . These authors put forward the hypothesis that hyperparathyroidism, which is almost invariably present in chronic renal failure (Gilmour, 1947; Ellis and Peart, 1973) , may account for tissue mast cell proliferation since there is evidence to suggest in experimental animals that parathormone stimulates the accumulation of mast cells in bone (Rockoff and Armstrong, 1970; Rasmussen, 1972) . This could be the explanation for the excess of mast cells in the fibrous tissue component of the osteitis fibrosa and in the remaining nonfibrous marrow. To test this hypothesis we have tried to relate the severity of the osteitis fibrosa, representing the degree of hyperparathyroidism, to the number of mast cells both in the marrow as a whole and in the non-fibrous marrow. The results showed a tendency towards greater numbers of mast cells in those bone samples with the more severe grades of osteitis fibrosa. When the combined renal biopsy and necropsy samples were considered, there was a low order of significant difference (P < 0-05) between the number of total marrow mast cells in the group with osteitis fibrosa grades 0 to 2 and that with grades 2-5 to 5. This difference was almost certainly associated with the greater amounts of fibrous tissue with mast cells in the marrow of the samples with more severe grades of osteitis fibrosa.
Thus there were similar numbers of mast cells in the non-fibrous parts of the marrow in the two osteitis fibrosa groupings in 24 individuals where differential counts of mast cells in fibrous and non-fibrous marrow were made. As another measure of hyperparathyroidism (Ellis and Peart, 1973) we considered the number of osteoclasts per square millimetre of bone in relation to the number of mast cells but there was no significant relationship. We therefore have no definite evidence to indicate a relationship between the degree of hyperparathyroidism and the number of marrow mast cells. Indeed, what evidence exists suggests that there may not be any direct relationship. Preliminary observations we have made in serial bone biopsies from patients with chronic renal failure before and after treatment with calcium carbonate and aluminium hydroxide or by parathyroidectomy, and in whom there has been a fall in serum parathormone and a reduction in the severity of osteitis fibrosa histologically, have shown no corresponding reduction in the excess of mast cells. This is against the hypothesis that there is a relationship between hyperparathyroidism and numbers of marrow mast cells. A further difficulty in any attempt to relate the number of marrow mast cells to the degree of osteitis fibrosa is the duration of the changes. The number of mast cells may be a function of the stage of development of the osteitis fibrosa and the age of the marrow fibrous tissue component. By analogy with the changing numbers of mast cells in the processes of organization and repair elsewhere, such as in the healing of a wound (Wichmann, 1955) , one would expect most mast cells to be present during the active phase of marrow fibrosis and subsequently to be reduced. Johnstone (1954) observed that the presence and number of mast cells in the marrow were not related to the iron content of the marrow or to the degree of erythropoiesis and that anaemia was the only factor common to all the cases in which mast cells were prominent. The majority of our patients with chronic renal failure had some degree of anaemia but there was no relationship between the number of marrow mast cells and the haemoglobin concentration of the blood within the group of renal patients.
There are no data in the literature strictly comparable with that presented here but Rebel et al (1974) have reported marrow mast cell counts in 21 patients with renal failure treated by haemodialysis in the range 0 to 600 per mm2, which is within the range we have found in renal failure. These authors do not report any control values however. In 11 other patients with, for example, osteomalacia or osteoporosis, the range was 0 1 to 23-0 mast cells per mmn2 of marrow. Highest marrow mast cell values were observed in patients with osteomalacia whether this was the result of renal failure or other causes, and the authors suggested that osteomalacia alone is sufficient to bring about an increase in the number of marrow mast cells. We were unable to confirm this relationship between osteomalacia and numbers of marrow mast cells in our patients with chronic renal failure, and there was no significant relationship between numbers of mast cells and the amount of osteoid per cent of the measured bone area, or the percentage mineralization of cancellous bone. The nature of the bone changes in chronic azotaemia depends upon the severity and duration of the renal disease. Hyperparathyroidism occurs at an early stage, so that in an unselected series of patients with chronic renal failure one can expect about 90% to show histological evidence of osteitis fibrosa whereas osteomalacia, which develops later, occurs in only about one-third (Ellis and Peart, 1973) . In any unselected series of patients with chronic renal failure the duration and severity of osteomalacia will vary from case to case. The rate of formation of osteoid also seems to vary so that some patients show relatively little increase in osteoid in serial biopsies whereas in others it is more rapid, and large amounts of osteoid accumulate and make a significant contribution to osteosclerosis. If there is a relationship between the numbers of marrow mast cells and osteomalacia then it might be that mast cells are associated with some particular stage in the development or persistence of osteomalacia. The incidence of osteomalacia in haemodialysed patients increases with time on dialysis (Ellis and Peart, 1971a) so that in a series of dialysed patients, such as that reported by Rebel et al (1974) , some patients would have recent and active development of osteomalacia. If this early stage of osteomalacia is associated with increased marrow mast cells, then this could explair the discrepancy between the results of these authors in haemodialysed patients and in our own non-dialysed patients. We are currently accumulating data on patients treated by long-term haemodialysis who have developed osteomalacia and we hope to be able to elucidate this aspect of the problem in the future. Increased numbers of mast cells alongside bone cancellous trabeculae have been described in rats on a low-calcium and vitamin D deficient diet (Shipley et al, 1922; Urist and McLean, 1957; Cass et al, 1958) and the mast cells were reduced in number after treatment with vitamin D. Increased numbers of marrow mast cells appear to be associated with experimental resorption and remodelling of bone whatever the cause (Gillman, 1958; Lalich, Groupner, and Jolin, 1965; Severson, 1969) , and it is possible that the presence of excess mast cells in azotaemia is a secondary manifestation 953 of bone resorption and formation. The precise relationship between mast cells and bone resorption and formation does not appear to have been resolved. Local effects of heparin may be responsible since it is known that the administration of heparin and similar but synthetic polysaccharides to experimental animals is associated with bone resorption and impaired ossification (Gillman and Naidoo, 1957; Ellis, 1965) . Osteoporosis has also been reported following the long-term administration of heparin to patients (Griffith et al, 1965; Jaffe and Willis, 1965; Schuster et al, 1969) . The mechanisms involved are unknown although it has been shown that heparin stimulates collagenase activity Sakamoto et al, 1973) and that heparin is capable of releasing lysozymal enzymes which might be involved in bone resorption (Sledge and Blackburn, 1968) . It has been shown (Ellis and Peart, 1970 ) that heparin increases the resorption of diaphyseal bone in cultured mouse limb bones, suggesting that there is a direct effect of heparin on bone. This effect occurred, however, only with higher concentrations of heparin than are reached in the blood and tissues of intact animals even after prolonged administration. For the in vivo changes to be the result of a direct toxic effect on bone there would have to be a selective accumulation of heparin in bone tissues. The excess marrow mast cells in the present cases are, of course, already near to the bone, and there might be localized zones of high heparin concentration. Others have suggested that the bone resorptive effect of heparin is an indirect one and mediated through hyperparathyroidism resulting from the hypocalcaemia following the binding of serum calcium ions by heparin (Hahnemann, 1965) . This hypothesis is not borne out by the observations that calcium heparin is equally effective as sodium heparin in inducing osteoporosis (Ellis, 1965) and that parathyroidectomy does not prevent development of heparinoid osteopathy (Ellis and Peart, 1971b) . There is also evidence from tissue culture experiments to suggest that heparin may enhance bone resorption by acting as a parathormone cofactor (Goldhaber, 1965) .
In discussing the possible local effects on bone of mast cells, one has to consider the relatively rare condition of systemic mastocytosis where there is infiltration of the skin and other tissue by mast cells (Sagher and Even-Paz, 1967) . Bone sections have been reported as showing resorption of trabeculae related to collections of mast cells, deposition of fibrillary lamellar bone, and trabecular thickening, marrow fibrosis, and osteosclerosis (Stark et al, 1956; Jensen and Lasser, 1958; Havard and Scott, 1959; Lerner and Lemer, 1960 
